Previous studies have demonstrated the activation of NLRP3 inflammasome and elevation of IL1B in the brains of AD patients and AD transgenic mice, such as the APP/PS1 and 5xFAD mice [3, 4, 32, 33]. This evidence concerns the gene NLRP3 and Alzheimer disease.